Skip to main content

Published locations for Arcalyst gets FDA nod as first therapy for recurrent pericarditis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Arcalyst gets FDA nod as first therapy for recurrent pericarditis

User login

  • Reset your password
  • /content/arcalyst-gets-fda-nod-first-therapy-recurrent-pericarditis
  • /familypracticenews/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy
  • /internalmedicinenews/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy
  • /rheumatologynews/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy
  • /jcomjournal/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy-recurrent
  • /ecardiologynews/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy
  • /cardiology/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy-recurrent
  • /rheumatology/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy-recurrent
  • /internalmedicine/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy
  • /familymedicine/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy-recurrent
  • /chestphysician/article/237731/acute-coronary-syndromes/arcalyst-gets-fda-nod-first-therapy-recurrent